ChiCTR2400093675 版本V1.0 版本创建时间2024/12/10 11:36:46 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400093675 

最近更新日期:

Date of Last Refreshed on:

2024-12-10 11:36:40 

注册时间:

Date of Registration:

2024-12-10 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

前庭功能障碍患者的认知功能现况调查

Public title:

Cross-sectional Survey on Cognitive Function in Patients with Vestibular Dysfunction

注册题目简写:

English Acronym:

研究课题的正式科学名称:

前庭功能障碍患者的认知功能现况调查

Scientific title:

Cross-sectional Survey on Cognitive Function in Patients with Vestibular Dysfunction

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张睿琦 

研究负责人:

吴沛霞 

Applicant:

Zhang Ruiqi 

Study leader:

Wu Peixia 

申请注册联系人电话:

Applicant telephone:

+86 166 2159 6397

研究负责人电话:

Study leader's telephone:

+86 135 2484 4652

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

22211170060@m.fudan.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

13524844652@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市闵行区浦江镇江月路2600号

研究负责人通讯地址:

上海市闵行区浦江镇江月路2600号

Applicant address:

2600 Jiangyue Road, Pujiang Town, Minhang District, Shanghai

Study leader's address:

2600 Jiangyue Road, Pujiang Town, Minhang District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

200031

研究负责人邮政编码:

Study leader's postcode:

200031

申请人所在单位:

复旦大学附属眼耳鼻喉科医院

Applicant's institution:

Eye & ENT Hospital, Fudan University

研究负责人所在单位:

复旦大学附属眼耳鼻喉科医院

Affiliation of the Leader:

Eye & ENT Hospital, Fudan University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2024]伦审字第(2024088)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

复旦大学附属眼耳鼻喉科医院伦理委员会

Name of the ethic committee:

Ethics Committee of Eye & ENT Hospital of Fudan University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-05-24 00:00:00

伦理委员会联系人:

吴仪菡

Contact Name of the ethic committee:

Wu Yihan

伦理委员会联系地址:

上海市徐汇区汾阳路83号

Contact Address of the ethic committee:

83 Fenyang Road, Xuhui District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 5419 0122

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

复旦大学附属眼耳鼻喉科医院

Primary sponsor:

Eye & ENT Hospital of Fudan University

研究实施负责(组长)单位地址:

上海市徐汇区汾阳路83号

Primary sponsor's address:

83 Fenyang Road, Xuhui District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属眼耳鼻喉科医院

具体地址:

徐汇区汾阳路83号

Institution
hospital:

Eye & ENT Hospital of Fudan University

Address:

83 Fenyang Road, Xuhui District

经费或物资来源:

研究者自筹

Source(s) of funding:

Self-raised by researchers

Target disease:

vestibular dysfunction

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

探究前庭功能障碍对认知功能的影响程度,能并分析前庭功能障碍患者认知功受损特征及相关影响因素  

Objectives of Study:

To investigate the extent of cognitive impairment associated with vestibular dysfunction and analyze the characteristics and influencing factors of cognitive deficits in patients with vestibular dysfunction.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)性别不限,年龄在18-70岁之间;(2)确诊为单侧前庭功能障碍的患者;(3)右利手;(4)患者知情同意,自愿参加。

Inclusion criteria

(1) Gender unrestricted, aged 18-70 years; (2) Patients diagnosed with unilateral vestibular dysfunction; (3) Right-handed; (4) Patients who have provided informed consent and voluntarily participate.

排除标准:

(1)合并神经肌肉疾病,影响活动功能者;(2)有精神、心理疾病史者; (3)曾有认知功能下降者;(4)有严重视觉或听觉障碍的患者;(5)研究者认为具有其他不适合参加本次临床研究的理由(如预估完成检查难度大、低依从性表现明显等)。

Exclusion criteria:

(1) Concurrent neuromuscular diseases affecting motor function; (2) History of psychiatric or psychological disorders; (3) History of cognitive impairment; (4) Severe visual or auditory impairments; (5) Other reasons deemed by the investigators as unsuitable for participation in this clinical study (e.g., anticipated difficulty in completing assessments, low compliance).

研究实施时间:

Study execute time:

From 2024-05-31 00:00:00 To 2030-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-04 00:00:00 To 2030-05-31 00:00:00  

干预措施:

Interventions:

组别:

前庭功能障碍组

样本量:

1000

Group:

Vestibular dysfunction group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China 

Province:

Shanghai 

City:

 

单位(医院):

复旦大学附属眼耳鼻喉科医院 

单位级别:

三级甲等 

Institution
hospital:

Eye & ENT Hospital of Fudan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

认知功能

指标类型:

主要指标

Outcome:

cognitive function

Type:

Primary indicator

测量时间点:

测量方法:

简易智能精神状态检查量表、蒙特利尔评估量表

Measure time point of outcome:

Measure method:

Simple intelligent mental state checklist/Montreal Cognitive Assessment

指标中文名:

前庭功能

指标类型:

主要指标

Outcome:

vestibular function

Type:

Primary indicator

测量时间点:

测量方法:

视频眼震电图、感觉统合试验、头脉冲试验、前庭诱发肌源性电位

Measure time point of outcome:

Measure method:

Videonystagmography/Sensory Organization Test/Video Head Impulse Test/Vestibular Evoked Myogenic Potentials

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

该研究为观察性研究(横断面研究),不按照随机方法进行分组。拟纳入研究期限内符合入组标准的全部受试者,直至达预期样本量。

Randomization Procedure (please state who generates the random number sequence and by what method):

The study was observational (cross-sectional) and was not randomized. All subjects who met the enrollment criteria during the proposed study period were included until the expected sample size was reached.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究发表后 https://www.medresman.org.cn/login.aspx

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After publishment, https://www.medresman.org.cn/login.aspx

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表及电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case record form and data collection and management system.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-12-10 11:36:40